1 completed, 1 not yet recruiting, 1 recruiting. 3 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 1, Not yet recruiting 1, Recruiting 1 |
| Phase 2 | 1 | Not yet recruiting 1 |
Follow envafolimab: new trials by email Literature Review of envafolimab trials Research Report on envafolimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC) Cetuxima-β, Envafolimab, mFOLFOX6 - Metastatic Colorectal Cancer (CRC) | Phase 2 / Phase 3 | Not yet recruiting | Sun Yat-sen University | 590 | 2025-06-01 | 2025-05-06 |
| Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma Envafolimab - Rectal Cancer | Phase 3 | Recruiting | Sir Run Run Shaw Hospital | 108 | 2023-04-01 | 2026-09-24 |
| Programmed Death Ligand (PD-L1) Combined With Chemotherapy for Patients With BTC KN035 plus Gemcitabine & oxaliplatin, Gemcitabine & oxaliplatin - Biliary Tract Neoplasms | Phase 3 | Completed | 3D Medicines (Sichuan) Co., Ltd. | 472 | 2018-04-16 | 2026-09-23 |
Biliary Tract Neoplasms (1) · Colorectal Neoplasms (1) · Rectal Neoplasms (1)
3D Medicines (Sichuan) Co., Ltd. (1) · Sir Run Run Shaw Hospital (1) · Sun Yat-sen University (1)
China (3)
Shukui Qin (1)